Skip to content
Stop using now Drug recall · FDA · Published May 10, 2013

Apotex Recalls Piperacillin/Tazobactam Vials Due to Crystallization Risk

Apotex recalls 52,398 vials of Piperacillin and Tazobactam for Injection due to potential crystallization. Check lot numbers 503B023-503C020.

🇺🇸 FDA recall #D-835-2013DrugApotex ›
Take action

Contact the company

Recalling firmApotex Corp.2400 N Commerce Pkwy Ste 400 · Weston, FL 33326-3253
✎ GovInfoNow plain-language explainer

What happened, in plain English

Apotex Corp. is recalling approximately 52,398 Pharmacy Bulk Package vials of Piperacillin and Tazobactam for Injection because the drug may crystallize when reconstituted. This precipitation can occur in the IV bag or line, which poses a serious safety risk if administered to patients. The recall affects specific lots manufactured by Hospira Healthcare India Pvt. Ltd. distributed nationwide. Read more at govinfonow.com/recall/47930-apotex-corp-recalls-piperacillin-and-tazobactam-for-injection-usp-40.

Source Summary by GovInfoNow · govinfonow.com/recall/47930-apotex-corp-recalls-piperacillin-and-tazobactam-for-injection-usp-40 · Updated October 13, 2026 · FDA enforcement record: FDA #D-835-2013

Cite this page

“Apotex Recalls Piperacillin/Tazobactam Vials Due to Crystallization Risk.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/47930-apotex-corp-recalls-piperacillin-and-tazobactam-for-injection-usp-40. Based on FDA recall #D-835-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-835-2013%22&limit=1).

Why it’s dangerous

The hazard is that the medication may exhibit precipitation or crystallization in the IV bag or line after reconstitution. If administered, these crystals could cause serious adverse events for the patient, as the integrity of the sterile injectable product is compromised.

Who’s affected

Healthcare facilities and pharmacies that purchased these specific Pharmacy Bulk Package vials are affected. Patients receiving this medication from the recalled lots are at risk of exposure to crystallized drug particles.

How to tell if you have this one

Check if you have Pharmacy Bulk Package vials of Piperacillin and Tazobactam for Injection, USP, 40.5 grams, manufactured by Hospira for Apotex Corp. Look for NDC 60505-0773-0 and the following lot numbers: 503B023 (Exp. 08/13); 503B028 through 503B033 (Exp. 11/13); 503C001 through 503C004 (Exp. 12/13); 503C009 (Exp. 01/14); 503C010, 503C011, 503C012, 503C014 (Exp. 02/14); and 503C015, 503C016, 503C017, 503C019, 503C020 (Exp. 04/14).

  • Brand
    Apotex
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop Using Recalled Lots

    Immediately stop using any vials matching the listed lot numbers and expiration dates.

  2. Contact Apotex Corp

    Reach out to Apotex Corp. in Weston, FL for further instructions on returning or disposing of the product.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 4.7 years after the firm started it.

1. Firm started the recall: May 10, 201312. FDA classified it Class I: Aug 2, 201323. Published in FDA’s Enforcement Report: Aug 14, 201334. FDA terminated the recall: Jan 8, 2018420132018
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Which lot numbers are included in this recall?

The recalled lots are 503B023, 503B028-503B033, 503C001-503C004, 503C009, 503C010-503C012, 503C014, and 503C015-503C017, 503C019-503C020.

Similar recalls

Other Apotex recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-835-2013 (May 10, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-835-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA